Literature DB >> 19385042

Roles and regulation of secretory and lysosomal acid sphingomyelinase.

Russell W Jenkins1, Daniel Canals, Yusuf A Hannun.   

Abstract

n class="Gene">Acid sphingomyelinase occupies a prominent position in n>n class="Chemical">sphingolipid catabolism, catalyzing the hydrolysis of sphingomyelin to ceramide and phosphorylcholine. Enzymatic dysfunction of acid sphingomyelinase results in Niemann-Pick disease, a lysosomal storage disorder characterized at the cellular level by accumulation of sphingomyelin within the endo-lysosomal compartment. Over the past decade interest in the role of acid sphingomyelinase has moved beyond its "housekeeping" function in constitutive turnover of sphingomyelin in the lysosome to include study of regulated ceramide generation. Ceramide functions as a bioactive sphingolipid with pleiotropic signaling properties, and has been implicated in diverse cellular processes of physiologic and pathophysiologic importance. Though many cellular enzymes have the capacity to generate ceramide,there is growing appreciation that "all ceramides are not created equal." Ceramides likely exert distinct effects in different cellular/subcellular compartments by virtue of access to other sphingolipid enzymes (e.g.ceramidases), effector molecules (e.g. ceramide-activated protein phosphatases), and neighboring lipids and proteins (e.g. cholesterol, ion channels). One of the unique features of acid sphingomyelinase is that it has been implicated in the hydrolysis of sphingomyelin in three different settings--the endo-lysosomal compartment,the outer leaflet of the plasma membrane, and lipoproteins. How a single gene product has the capacity to function in these diverse settings, and the subsequent impact on downstream ceramide-mediated biology is the subject of this review.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19385042      PMCID: PMC3488588          DOI: 10.1016/j.cellsig.2009.01.026

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  189 in total

1.  Posttranslational regulation of acid sphingomyelinase in niemann-pick type C1 fibroblasts and free cholesterol-enriched chinese hamster ovary cells.

Authors:  J W Reagan; M L Hubbert; G S Shelness
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

2.  Functional characterization of the N-glycosylation sites of human acid sphingomyelinase by site-directed mutagenesis.

Authors:  K Ferlinz; R Hurwitz; H Moczall; S Lansmann; E H Schuchman; K Sandhoff
Journal:  Eur J Biochem       Date:  1997-01-15

3.  Lysosomal sphingomyelinase is not solicited for apoptosis signaling.

Authors:  C Bezombes; B Ségui; O Cuvillier; A P Bruno; E Uro-Coste; V Gouazé; N Andrieu-Abadie; S Carpentier; G Laurent; R Salvayre; J P Jaffrézou; T Levade
Journal:  FASEB J       Date:  2000-12-08       Impact factor: 5.191

4.  Sphingomyelinase converts lipoproteins from apolipoprotein E knockout mice into potent inducers of macrophage foam cell formation.

Authors:  S Marathe; Y Choi; A R Leventhal; I Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-12       Impact factor: 8.311

5.  Purification of acid sphingomyelinase from human placenta: characterization and N-terminal sequence.

Authors:  S Lansmann; K Ferlinz; R Hurwitz; O Bartelsen; G Glombitza; K Sandhoff
Journal:  FEBS Lett       Date:  1996-12-16       Impact factor: 4.124

Review 6.  Stimulation of lysosomal sphingomyelin degradation by sphingolipid activator proteins.

Authors:  K Ferlinz; T Linke; O Bartelsen; M Weiler; K Sandhoff
Journal:  Chem Phys Lipids       Date:  1999-11       Impact factor: 3.329

Review 7.  Secretory sphingomyelinase.

Authors:  I Tabas
Journal:  Chem Phys Lipids       Date:  1999-11       Impact factor: 3.329

8.  Acceleration by ceramide of calcium-dependent translocation of phospholipase A2 from cytosol to membranes in platelets.

Authors:  K Kitatani; T Oka; T Murata; M Hayama; S Akiba; T Sato
Journal:  Arch Biochem Biophys       Date:  2000-10-15       Impact factor: 4.013

9.  Cell autonomous apoptosis defects in acid sphingomyelinase knockout fibroblasts.

Authors:  J Lozano; S Menendez; A Morales; D Ehleiter; W C Liao; R Wagman; A Haimovitz-Friedman; Z Fuks; R Kolesnick
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

10.  Functional analysis of the glycosylation of murine acid sphingomyelinase.

Authors:  D Newrzella; W Stoffel
Journal:  J Biol Chem       Date:  1996-12-13       Impact factor: 5.157

View more
  122 in total

1.  SrfJ, a Salmonella type III secretion system effector regulated by PhoP, RcsB, and IolR.

Authors:  Mar Cordero-Alba; Joaquín Bernal-Bayard; Francisco Ramos-Morales
Journal:  J Bacteriol       Date:  2012-06-01       Impact factor: 3.490

2.  Sequential action of Caenorhabditis elegans Rab GTPases regulates phagolysosome formation during apoptotic cell degradation.

Authors:  Pengfei Guo; Tianjing Hu; Juan Zhang; Shanya Jiang; Xiaochen Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

Review 3.  Damage control: cellular mechanisms of plasma membrane repair.

Authors:  Norma W Andrews; Patricia E Almeida; Matthias Corrotte
Journal:  Trends Cell Biol       Date:  2014-08-20       Impact factor: 20.808

4.  Acid sphingomyelinase plays a critical role in LPS- and cytokine-induced tissue factor procoagulant activity.

Authors:  Jue Wang; Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Blood       Date:  2019-07-01       Impact factor: 22.113

Review 5.  Evolving concepts in cancer therapy through targeting sphingolipid metabolism.

Authors:  Jean-Philip Truman; Mónica García-Barros; Lina M Obeid; Yusuf A Hannun
Journal:  Biochim Biophys Acta       Date:  2013-12-30

Review 6.  Role of sphingolipids in the biogenesis and biological activity of extracellular vesicles.

Authors:  Claudia Verderio; Martina Gabrielli; Paola Giussani
Journal:  J Lipid Res       Date:  2018-05-31       Impact factor: 5.922

Review 7.  Sphingolipids in mitochondria.

Authors:  María José Hernández-Corbacho; Mohamed F Salama; Daniel Canals; Can E Senkal; Lina M Obeid
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-09-30       Impact factor: 4.698

8.  Ezetimibe inhibits expression of acid sphingomyelinase in liver and intestine.

Authors:  Yajun Cheng; Fuli Liu; Jun Wu; Yao Zhang; Ake Nilsson; Rui-Dong Duan
Journal:  Lipids       Date:  2009-09-24       Impact factor: 1.880

9.  The role of sphingolipids and ceramide in pulmonary inflammation in cystic fibrosis.

Authors:  Katrin Anne Becker; Joachim Riethmüller; Yang Zhang; Erich Gulbins
Journal:  Open Respir Med J       Date:  2010-03-30

Review 10.  Sphingolipids: the nexus between Gaucher disease and insulin resistance.

Authors:  Maria Fuller
Journal:  Lipids Health Dis       Date:  2010-10-11       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.